ArticleScientific reports2025
Colistin- and cefotaxime-resistant Shiga toxin-producing Escherichia coli (STEC) in buffalo meat.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In this study, Shiga toxin-producing E. coli (STEC) were detected in 64% of all tested buffalo meat samples, distributed as 62% of buffalo meat chops and 66% of ground buffalo meat. Six serotypes (O55:H7, O111:H8, O145, O157:H7, O26:H11, and O103:H2) were identified, of which, O55:H7 (37.26%) and O111:H8 (21.29%) were the most predominant. The eaeA, stx1, stx2, and EHEC-hlyA were detected by multiplex PCR in all E. coli isolates at different percentages, and multiple virulence patterns with stx2/stx1/eae were the most prevalent pattern indicating that the serotypes will be more virulent in pathogenesis. The isolates showed high resistance rates against Erythromycin (100%), Clindamycin (86.7%), Nalidixic acid (84.4%), Cefepime (73.4%), and Ampicillin (62.7%), Cefazolin (53.2%) and Tetracycline (51.7%) and most of the isolates (73%) were classified as multi-drug resistant (MDR). For the first time, we identified a high frequency of Cefotaxime-resistant (28.5%) and Colistin-resistant (16.3%) E. coli from buffalo meat and this becomes a huge problem because Cefotaxime and colistin are typically used as a last resort to treat complex infections caused by multidrug-resistant Gram-negative bacilli. The emergence of virulent and multidrug-resistant E. coli strains in food seriously threatens human health. This highlights the need for antimicrobial stewardship programs in developing countries like Egypt to minimize the spread and emergence of these strains and prevent their dissemination to humans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.